Literature DB >> 27392817

Successful long-term outcome of liver transplantation in late-onset lysosomal acid lipase deficiency.

S Sreekantam1, I Nicklaus-Wollenteit2, J Orr3, K Sharif4, S Vijay1, P J McKiernan4, S Santra1.   

Abstract

Late-onset LAL deficiency, previously referred to as cholesteryl ester storage disorder, is a rare lysosomal storage disorder characterized by accumulation of cholesteryl esters. It has a heterogeneous clinical phenotype including abdominal pain, poor growth, hyperlipidemia with vascular complications and hepatosplenomegaly. End-stage liver disease may occur, but there are few reports of successful LT. There are also concerns that systemic manifestations of the disease might persist post-LT. We report a case with excellent outcome eight yr following LT. The subject was noted to have asymptomatic hepatosplenomegaly during an intercurrent illness, and LAL deficiency was confirmed with compound heterozygosity in the LIPA. Despite dietary fat restriction, he developed signs of progressive liver disease and subsequently developed hepatopulmonary syndrome. He underwent cadaveric LT at the age of nine and a half yr and recovered with prompt resolution of hepatopulmonary syndrome. Eight yr post-transplant he has normal growth, normal lipid profile, and liver and renal function tests. Liver histology showed no evidence of disease recurrence at this stage. LT in this subject resulted in an excellent functional correction of late-onset LAL deficiency.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  LAL deficiency; cholesteryl ester storage disorder; late onset acid lipase deficiency; liver transplantation

Mesh:

Year:  2016        PMID: 27392817     DOI: 10.1111/petr.12748

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

1.  Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature.

Authors:  Elias Badal Rashu; Anders Ellekær Junker; Karen Vagner Danielsen; Emilie Dahl; Ole Hamberg; Line Borgwardt; Vibeke Brix Christensen; Nicolai J Wewer Albrechtsen; Lise L Gluud
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

2.  Living-Donor Liver Transplantation for Late-Onset Lysosomal Acid Lipase Deficiency.

Authors:  Somashekara H Ramakrishna; Mohan B Kasala; Karnan Perumal; Selvakumar Malleeswaran; Rajanikanth V Patcha; Joy Varghese
Journal:  J Clin Exp Hepatol       Date:  2021-07-06

3.  Lysosomal Acid Lipase Deficiency, a Rare Pathology: The First Pediatric Patient Reported in Colombia.

Authors:  Verónica Botero; Victor H Garcia; Catalina Gomez-Duarte; Ana M Aristizabal; Ana M Arrunategui; Gabriel J Echeverri; Harry Pachajoa
Journal:  Am J Case Rep       Date:  2018-06-09

4.  Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up.

Authors:  Tanguy Demaret; Florence Lacaille; Camille Wicker; Jean-Baptiste Arnoux; Juliette Bouchereau; Claire Belloche; Cyril Gitiaux; David Grevent; Christine Broissand; Dalila Adjaoud; Marie-Thérèse Abi Warde; Dominique Plantaz; Soumeya Bekri; Pascale de Lonlay; Anaïs Brassier
Journal:  Orphanet J Rare Dis       Date:  2021-12-14       Impact factor: 4.123

5.  Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency.

Authors:  Amanda Barone Pritchard; Alanna Strong; Can Ficicioglu
Journal:  Orphanet J Rare Dis       Date:  2020-02-24       Impact factor: 4.123

Review 6.  Lysosomal acid lipase deficiency in pediatric patients: a scoping review.

Authors:  Camila da Rosa Witeck; Anne Calbusch Schmitz; Júlia Meller Dias de Oliveira; André Luís Porporatti; Graziela De Luca Canto; Maria Marlene de Souza Pires
Journal:  J Pediatr (Rio J)       Date:  2021-05-06       Impact factor: 2.990

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.